openPR Logo
Press release

Penile Cancer Market : Set for Rapid Growth and Trend by 2020

01-02-2018 10:20 AM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Penile Cancer Market : Set for Rapid Growth and Trend by 2020

Cancer, according to the International Agency for Research on Cancer (IARC) resulted in the death of around 4.6 million men worldwide in 2012. Around 14% of the world’s total annual deaths are as a result of various cancers. Modern medicine has extended the life expectancy of a cancer patient by a great margin. However newer cases are diagnosed every year globally, the present rate stands at 7.4 million newly diagnosed males annually, according to the WHO. This is commonly as a result of the changing lifestyles, unhealthy diet, hereditary factors and exposure to carcinogenic elements, cigarette smoking, etc. Male specific cancers include: prostate cancer, testicular cancer, and penile cancer. Among which prostate cancer is the most prevalent form of male cancer. Male specific cancers are generally benign/malignant tumors that rarely undergo metastasis.
 
Penile cancers are an even rarer form of cancer specific to the male reproductive organ i.e. penis, but unlike prostate and testicular cancer, they are commonly as a result of human papiloma virus (HPV), and human immunodeficiency virus (HIV) infection. According to the U.S National Cancer Institute study roughly 40% of all penile cancer is as a result of HPV infections, whereas HIV patients exhibit eight time increased risk of penile cancer. Hence penile cancer rates are high in developing countries of Africa, South Asia and South America. This is probably why vaccination for HPV virus (Gardasil or Cervarix) is regarded by a share of expert medical practitioners as a preventive measure in decreasing penile cancer rates globally. The incidence rate for penile cacner is found higher in men above 30 years of age,   Penile cancer is majorly categorized as squamous cell carcinoma, as a large majority of penile cancer patients have exhibited this form. Other even rare types include intraepithelial neoplasia, bowenoid papulosis and invasive carcinoma of the penis.
 
Request Brochure Copy of the report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3573
The diagnosis of penile cancer is initially done by physical examination of the penis, this is followed by the biopsy of the outgrowth i.e. wart/ papules or skin abscess. Staging of the penile malignancy is done further to establish a timeline of disease progression. Chemotherapy, antiviral therapy and surgical excision are the common mode of treatment for penile cancer. Surgical methods are classified on the type of procedure apt to remove the tumor; circumcision, microsurgery, excision, or penectomy (castration) are the generally followed procedures. Radiation is used to prevent any reoccurrence, although the procedure can render the patient infertile.
That said, the market for male cancer therapeutics is highly fragmented hence not easily quantifiable, however the surgery and overall treatment market remains in millions of USD, with new  diagnostic screening procedures and drug combinations being patented every year, each having their own market segment. With entry of Asian players the prices too are bound to decrease, thereby potentially increasing the overall therapeutics market.
 
The North American market is the highest market by volume, followed by Europe, as in these regions the number of reported cases are high in number, and so is the affordability of drugs. In developing markets of Asia and South America, their poor hygiene standards, presence of a large HIV patient population along with their overall increasing population size make for a large market, however unavailability of affordable diagnostic procedures and therapeutic drugs is thought to be the major reason why diagnosis is few in number and why the markets haven’t been proliferated as of yet. The rest of the world region is also bound to follow a similar pattern with increased awareness and diagnostic rates, the number of diagnosed individuals undergoing therapy in this region is however very small.
 
Request Discount @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=3573
Some of the major companies manufacturing HPV vaccines include: GlaxoSmithKline PLC, Novartis AG, MercK & Co, etc to name a few.
 
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
North America
Asia Pacific
Europe
Rest of the World
This report provides comprehensive analysis of 
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
 
Report Details @ https://www.transparencymarketresearch.com/penile-cancer-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Penile Cancer Market : Set for Rapid Growth and Trend by 2020 here

News-ID: 880955 • Views: 275

More Releases from Transparency Market Research

Wearable EEG Devices Market: Growing incidences of Neurovascular Disorders is Dr …
According to new market research titled 'Wearable EEG Devices Market to 2027 - Global Analysis and Forecasts by Channel and Application.' The global wearable EEG devices market is expected to reach US$ 1,556.35 Mn in 2027 from US$ 745.05 Mn in 2018. The market is projected to grow with a CAGR of 8.7% from 2019-2027. The report provides trends prevailing in the global wearable EEG devices market and the factors
Decentralized Electricity Generation Market - Global Industry Analysis, Share, G …
Global Decentralized Electricity Generation Market: Overview With the increasing installation of smart grids and the rising number of electricity generation resources, the power generation industry has been undergoing a significant change over the recent past. The modification in the grid structure, which permits decentralization of electricity generation, is acting as the main driving force behind the substantial growth of the global market for decentralized electricity generation. The main objective of this research
Global Sucralose Market Outlook In The Developed And Emerging Industry
Sucralose Market Overview Sugar substitute market is witnessing an increasing demand driven by the increasing sales of various sugar substitutes such as natural sweeteners and artificial sweeteners. Sucralose, an artificial sweetener used as a sugar substitute is highly preferred by consumers owing to its zero calorie attribute. Though sucralose is 600 times sweeter than sugar but interestingly it is not identified as the carbohydrate by the human body. Sucralose has its
Flavored Syrup Market - Growth Powered with Latest Development Scenario & Influe …
Flavored Syrup Market Introduction Global syrup market is witnessing a significant demand generated by the food and beverage industry. Consumers' increasing preference for different and personalized flavors in food has driven the syrup manufacturers to produce a wide range of flavored syrups. Flavored syrups contain artificial or natural flavorings mixed along with sugar and water. Obtain Report Details @ https://www.transparencymarketresearch.com/flavored-syrup-market.html Increasing demand of flavored syrups especially among the consumers contributes to the

All 5 Releases


More Releases for Cancer

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and